Margot Johnson

3.8k total citations · 2 hit papers
9 papers, 2.7k citations indexed

About

Margot Johnson is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Margot Johnson has authored 9 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Internal Medicine and 3 papers in Surgery. Recurrent topics in Margot Johnson's work include Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Blood Pressure and Hypertension Studies (3 papers). Margot Johnson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Blood Pressure and Hypertension Studies (3 papers). Margot Johnson collaborates with scholars based in United States, United Kingdom and Netherlands. Margot Johnson's co-authors include Harry R. Büller, Jeffrey I. Weitz, Alexander Gallus, Giancarlo Agnelli, Madelyn Curto, John R. Thompson, Gary E. Raskob, Alexander T. Cohen, Urszula Masiukiewicz and Raphael Pak and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of the American College of Cardiology.

In The Last Decade

Margot Johnson

9 papers receiving 2.6k citations

Hit Papers

Oral Apixaban for the Treatment of Acute Venous Thromboem... 2012 2026 2016 2021 2013 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oral Apixaban for the Treatment of Acute Venous Thromboembolism
    2013 1.7k citations Giancarlo Agnelli, Harry R. Büller et al. New England Journal of Medicine profile →
  2. Apixaban for Extended Treatment of Venous Thromboembolism
    2012 918 citations Giancarlo Agnelli, Harry R. Büller et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margot Johnson United States 7 2.4k 2.2k 490 400 236 9 2.7k
Madelyn Curto United States 7 2.4k 1.0× 2.2k 1.0× 497 1.0× 395 1.0× 241 1.0× 11 2.8k
Alexander T Cohen Canada 10 2.3k 1.0× 1.9k 0.9× 558 1.1× 314 0.8× 518 2.2× 19 2.6k
Theodore E. Spiro United States 29 2.5k 1.0× 2.3k 1.1× 879 1.8× 319 0.8× 218 0.9× 66 3.4k
Raphael Pak Canada 10 1.7k 0.7× 1.6k 0.7× 424 0.9× 231 0.6× 226 1.0× 22 2.1k
Maria Cristina Vedovati Italy 24 1.9k 0.8× 1.6k 0.7× 487 1.0× 186 0.5× 292 1.2× 76 2.5k
Russel Hull Canada 10 1.5k 0.6× 1.1k 0.5× 508 1.0× 330 0.8× 299 1.3× 16 1.8k
Harry R. Büller Netherlands 18 1.6k 0.7× 1.1k 0.5× 582 1.2× 552 1.4× 317 1.3× 28 2.3k
Alexander G.G. Turpie Canada 15 2.1k 0.9× 1.6k 0.7× 591 1.2× 316 0.8× 441 1.9× 25 2.3k
H.R. Büller Netherlands 22 2.1k 0.9× 1.5k 0.7× 916 1.9× 873 2.2× 487 2.1× 50 2.8k
Francesco Dentali Italy 22 1.2k 0.5× 863 0.4× 389 0.8× 325 0.8× 283 1.2× 47 1.7k

Countries citing papers authored by Margot Johnson

Since Specialization
Citations

This map shows the geographic impact of Margot Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margot Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margot Johnson more than expected).

Fields of papers citing papers by Margot Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margot Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margot Johnson. The network helps show where Margot Johnson may publish in the future.

Co-authorship network of co-authors of Margot Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Margot Johnson. A scholar is included among the top collaborators of Margot Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margot Johnson. Margot Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Amin, Neeta B., Robert Frederich, Nikolaos Tsamandouras, et al.. (2024). Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study. Diabetes Obesity and Metabolism. 27(1). 215–227. 13 indexed citations
2.
Liu, Xianchen, John R. Thompson, Hemant Phatak, et al.. (2015). Extended anticoagulation with apixaban reduces hospitalisations in patients with venous thromboembolism. Thrombosis and Haemostasis. 115(1). 161–168. 12 indexed citations
3.
4.
Liu, Xianchen, Margot Johnson, Jack Mardekian, et al.. (2014). APIXABAN REDUCES HOSPITALIZATIONS IN PATIENTS WITH VTE: AN ANALYSIS OF THE AMPLIFY TRIAL. Journal of the American College of Cardiology. 63(12). A2045–A2045. 3 indexed citations
5.
Agnelli, Giancarlo, Harry R. Büller, Alexander T. Cohen, et al.. (2013). Oral Apixaban for the Treatment of Acute Venous Thromboembolism. New England Journal of Medicine. 369(9). 799–808. 1657 indexed citations breakdown →
6.
Liu, Xianchen, John R. Thompson, Hemant Phatak, et al.. (2013). Apixaban Reduces Hospitalization In Patients With Venous Thromboembolism: An Analysis Of The AMPLIFY-EXT Trial. Blood. 122(21). 3638–3638. 11 indexed citations
7.
Agnelli, Giancarlo, Harry R. Büller, Alexander Cohen, et al.. (2013). Apixaban for Extended Treatment of Venous Thromboembolism. Survey of Anesthesiology. 57(5). 263–264. 28 indexed citations
8.
Agnelli, Giancarlo, Harry R. Büller, Alexander T. Cohen, et al.. (2012). Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism. Blood. 120(21). LBA–1. 5 indexed citations
9.
Agnelli, Giancarlo, Harry R. Büller, Alexander T. Cohen, et al.. (2012). Apixaban for Extended Treatment of Venous Thromboembolism. New England Journal of Medicine. 368(8). 699–708. 918 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Madelyn Curto Breakdown of academic impact, for papers by Alexander T Cohen Breakdown of academic impact, for papers by Theodore E. Spiro Breakdown of academic impact, for papers by Raphael Pak Breakdown of academic impact, for papers by Maria Cristina Vedovati Breakdown of academic impact, for papers by Russel Hull Breakdown of academic impact, for papers by Harry R. Büller Breakdown of academic impact, for papers by Alexander G.G. Turpie Breakdown of academic impact, for papers by H.R. Büller Breakdown of academic impact, for papers by Francesco Dentali
Rankless by CCL
2026